Skip to contentM
Marimed Inc.
M
MRMDMarimed Inc. Q3 2019 · 10-Q
Revenue$4.21M$4.21M+24.1% vs Q3 2018 Net Income-$7.40M-$7.40MN/M vs Q3 2018 EPS Diluted-$0.03-$0.03N/M vs Q3 2018 Gross Profit$4,700,416+151.4% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Marimed Inc. · CIK 1522767 · Engraved from SEC EDGAR
Operating Cash Flowderived-$2,127,839N/M Free Cash Flowderived-$4,923,263N/M Margins · derivedGross margin111.7%+56.5 pt vs Q3 2018
Operating margin23.1%+39.3 pt vs Q3 2018
Net margin-175.8%−72.5 pt vs Q3 2018
ended Sep 30, 2019 · filed Nov 29, 2019 · 60 d after period end